Keytruda Qlex
Payments companies reported to CMS as associated with Keytruda Qlex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Keytruda Qlex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Keytruda Qlex
These are the largest totals companies reported as associated with Keytruda Qlex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Bunn | Aurora, CO | Medical Oncology | $1,830.00 |
| David Johnson | Dallas, TX | Medical Oncology | $1,525.00 |
| Brian Choi | Riverside, CA | $186.76 | |
| Samir Kubba | San Bernardino, CA | Hematology & Oncology | $164.36 |
| Ashwin Vasudevamurthy | Indianapolis, IN | Medical Oncology | $146.58 |
| Michael Sherman | Walnut Creek, CA | Hematology & Oncology | $141.92 |
| Michele Cleary | Brandywine, MD | Family | $135.38 |
| Eutiquio Gutierrez | Anaheim, CA | Internal Medicine | $131.72 |
| Janet William | Cerritos, CA | Nurse Practitioner | $129.74 |
| Heidi Chang | Walnut Creek, CA | Obstetrics & Gynecology | $129.11 |
Prescribed Keytruda Qlex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.